Update regarding the ongoing application process for national approval of
biocidal products (disinfection products) in Norway (with reference to the stock
exchange announcement from SoftOx Solutions AS (SoftOx) on September 22, 2021).

The Ministry of Climate and the Environment has not upheld the appeal against a
decision to reject the application for approval in parallel mutual recognition
of SoftOx disinfection. Pending a decision from Sweden, SoftOx must therefore
temporarily suspend the sale of SoftOx hand disinfectant. When SoftOx is
successful in Sweden, the product will be able to be replaced on the market in
Norway.

For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599

The information included in this announcement is defined as inside information
pursuant to MAR article 7, and is publicly disclosed in accordance with MAR
article 17. The announcement is made by the contact person. 

About SoftOx Solutions AS
SoftOx Solutions AS (Softx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange